Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 75.86 | nM | 11908989 | |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC50 | = | 80.1 | ug/ml | 24042007 |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 35.89 | nM | 15568791 | |
NPT2 | Others | Unspecified | IC50 | > | 100000 | nM | 2153829 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 49888.45 | nM | 2362284 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 4365.16 | nM | 16203143 | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 100 | ug disk-1 | 12350153 |
NPT4461 | Cell Line | Panel (Carcinoma cell lines) | Homo sapiens | GI50 | = | 16.2 | nM | 16933872 |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 65.77 | nM | 18327911 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 690.24 | nM | 23044367 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 14.83 | nM | 12398547 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 8933.05 | nM | 10479311 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 2924.15 | nM | 17125239 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 165.58 | nM | 21856049 | |
NPT2 | Others | Unspecified | Activity | = | 2.2 | % | 7562925 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 0.061 | ug/ml | 10543891 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 0.17 | ug/ml | 10543891 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 4.4 | ug/ml | 10543891 |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | = | 0.3 | ug/ml | 10543891 |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 75.68 | nM | 19075057 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 119.4 | nM | 16472241 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | = | 38.4 | nM | 21353349 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 15.3 | nM | 21353349 |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 1573.98 | nM | Open TG-GATES in vivo data: Organ Weight | |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 25 | % | Open TG-GATES in vivo data: Biochemistry |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 58.21 | nM | DrugMatrix in vivo data: Pathology | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.251 | ug/ml | 11606389 |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 255.86 | nM | 8984155 | |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC50 | = | 18 | ug/ml | 20189399 |
NPT3702 | Individual Protein | DNA topoisomerase 1 | Saccharomyces cerevisiae S288c | IC50 | = | 1.6 | ug/ml | 20189399 |
NPT3702 | Individual Protein | DNA topoisomerase 1 | Saccharomyces cerevisiae S288c | IC50 | = | 1.9 | ug/ml | 20189399 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC50 | = | 1.8 | ug/ml | 20189399 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC50 | = | 53 | ug/ml | 20189399 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC12 | = | 2.2 | ug/ml | 20189399 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC12 | = | 33.5 | ug/ml | 3572419 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 10 | nM | 16562838 | |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 4.4 | ug/ml | 25412141 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 259.42 | nM | 17585753 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 104.23 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | DailyMed | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.99 | ug/ml | DailyMed |
NPT168 | Cell Line | P388 | Mus musculus | Activity | = | 26 | % | DailyMed |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 66.53 | nM | 24328302 | |
NPT2 | Others | Unspecified | IC50 | = | 1900 | nM | 15787436 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 909.91 | nM | 15844943 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 1800 | nM | 10924160 |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 95.28 | nM | 8759172 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 50 | nM | 17049251 | |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 600 | nM | 1955885 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 68.23 | nM | 26295746 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 50 | nM | 15387655 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 13 | nM | 14738403 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 46 | nM | PubChem BioAssay data set |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 237.68 | nM | 16854066 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 740 | nM | 10.6019/CHEMBL1201861 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 75900 | nM | 21534539 |
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 138.68 | nM | 12502317 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 677.64 | nM | 2128517 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 45.08 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 110.92 | nM | 12852960 | |
NPT2 | Others | Unspecified | GI50 | = | 16.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 68.5 | ug | 22939698 | |
NPT2 | Others | Unspecified | Inhibition | = | 3 | % | 20801553 | |
NPT2 | Others | Unspecified | ID50 | = | 2 | nM | 18955526 | |
NPT2 | Others | Unspecified | IC50 | = | 1100 | nM | 20421396 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 178.24 | nM | 19506058 | |
NPT2 | Others | Unspecified | IC50 | = | 1900 | nM | 21078949 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 41.78 | nM | 22194678 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 1306.17 | nM | 22264752 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 94.19 | nM | 10.1007/s00044-013-0840-9 | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.2 | ug/ml | 10.1007/s00044-013-0720-3 |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 50 | nM | 24508829 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | IC50 | > | 100000 | nM | 18494522 |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 10 | nM | 23327794 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 900 | nM | 25028062 |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 330.37 | nM | 20553004 | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 14757.07 | nM | 23734744 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 69.82 | nM | 15620248 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 80.72 | nM | 23434131 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 264.85 | nM | 9514009 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 6652.73 | nM | 17844994 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 610.94 | nM | 17542634 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 39.36 | nM | 11277747 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 0.061 | ug/ml | 10.1016/S0960-894X(97)00060-7 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 50 | ug | 11602674 |
NPT1522 | Organism | Neisseria gonorrhoeae | Neisseria gonorrhoeae | MIC | = | 25 | ug | 15781124 |
NPT2 | Others | Unspecified | Activity | = | 89 | % | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | Activity | = | 99.6 | % | DrugMatrix in vitro pharmacology data | |
NPT781 | Individual Protein | Tubulin alpha chain | Sus scrofa | Inhibition | = | 99.6 | % | 10.6019/CHEMBL1201861 |
NPT781 | Individual Protein | Tubulin alpha chain | Sus scrofa | IC50 | = | 1100 | nM | 10.6019/CHEMBL1201861 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 0.74 | ug/ml | Open TG-GATES in vivo data: Biochemistry |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 95.28 | nM | DrugMatrix in vivo data: Hematology | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 22.65 | nM | 24262885 | |
NPT2 | Others | Unspecified | IC50 | = | 4000 | nM | 21051535 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 27.67 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 10.3 | nM | 25211032 | |
NPT1216 | Cell Line | FaDu | Homo sapiens | GI50 | = | 0.23 | ug/ml | 15217270 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 0.74 | ug/ml | 20429578 |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 2197.86 | nM | 20307086 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 1986.09 | nM | 10757713 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 2065.38 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 10 | nM | 12036352 | |
NPT1522 | Organism | Neisseria gonorrhoeae | Neisseria gonorrhoeae | MIC | = | 50 | ug disk-1 | 18805693 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 4400 | nM | 24900509 |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 43.45 | nM | 14987072 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 10 | nM | 25856683 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 61 | nM | 11975502 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 0.74 | ug/ml | 18303851 |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 69.66 | nM | 24087924 | |
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | = | 2.6 | nM | 20303767 |
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | = | 4.1 | nM | 20303767 |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 64.27 | nM | 16643036 | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 52.48 | nM | 23964704 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 88.1 | nM | 10212132 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 32.6 | nM | 23747224 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 78.52 | nM | 8277313 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 47.21 | nM | 17353252 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 7030.72 | nM | 18809939 | |
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 50 | nM | DrugMatrix in vitro pharmacology data | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 510 | nM | 23587837 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 2200 | nM | 23587837 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 46.34 | nM | 22377672 | |
NPT2 | Others | Unspecified | IC50 | = | 3200 | nM | 8786366 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 50 | nM | 18302334 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 0.63 | nM | 16616488 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.3 | ug/ml | PubChem BioAssay data set |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 122.74 | nM | DrugMatrix in vitro pharmacology data | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 15 | nM | PubChem BioAssay data set |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 112.2 | nM | DrugMatrix in vivo data: Hematology | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 22.34 | nM | 17118653 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 202.77 | nM | 9873651 | |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 4.4 | ug/ml | 18183025 |
NPT3014 | Protein Family | Tubulin | Sus scrofa | IC50 | = | 3500 | nM | 24216090 |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 89.33 | nM | 24164206 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 5407.54 | nM | 23434636 | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 26424.09 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 60.58 | ug | 20498323 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 0.17 | ug/ml | 19687244 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 170 | nM | DrugMatrix in vitro pharmacology data |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 154.53 | nM | 22705001 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 55.08 | nM | 15104496 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 33 | nM | 21130542 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | = | 38 | nM | 14987059 |
NPT2 | Others | Unspecified | IC50 | = | 1100 | nM | 26686929 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 0.17 | ug/ml | 15497935 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 12.74 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC82483 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC265483 |
1.0 | High Similarity | NPC299584 |
0.9916 | High Similarity | NPC44748 |
0.9916 | High Similarity | NPC28730 |
0.9916 | High Similarity | NPC78974 |
0.9916 | High Similarity | NPC214406 |
0.9916 | High Similarity | NPC223136 |
0.9916 | High Similarity | NPC18924 |
0.9916 | High Similarity | NPC103823 |
0.9833 | High Similarity | NPC169474 |
0.9833 | High Similarity | NPC159968 |
0.9833 | High Similarity | NPC74817 |
0.9833 | High Similarity | NPC124452 |
0.9833 | High Similarity | NPC236791 |
0.9833 | High Similarity | NPC293054 |
0.9833 | High Similarity | NPC282000 |
0.9833 | High Similarity | NPC82679 |
0.9833 | High Similarity | NPC246620 |
0.9833 | High Similarity | NPC324112 |
0.9832 | High Similarity | NPC234400 |
0.9832 | High Similarity | NPC60885 |
0.9831 | High Similarity | NPC95168 |
0.9746 | High Similarity | NPC71579 |
0.9746 | High Similarity | NPC262253 |
0.9746 | High Similarity | NPC473411 |
0.9672 | High Similarity | NPC58164 |
0.9672 | High Similarity | NPC10225 |
0.9667 | High Similarity | NPC221077 |
0.9667 | High Similarity | NPC251855 |
0.9667 | High Similarity | NPC57490 |
0.9667 | High Similarity | NPC208950 |
0.9667 | High Similarity | NPC233410 |
0.9667 | High Similarity | NPC116907 |
0.9667 | High Similarity | NPC117214 |
0.9667 | High Similarity | NPC203133 |
0.9667 | High Similarity | NPC193544 |
0.9667 | High Similarity | NPC475169 |
0.9667 | High Similarity | NPC298757 |
0.9667 | High Similarity | NPC472093 |
0.9667 | High Similarity | NPC105925 |
0.9667 | High Similarity | NPC17943 |
0.9661 | High Similarity | NPC75713 |
0.9593 | High Similarity | NPC234488 |
0.9593 | High Similarity | NPC299221 |
0.9593 | High Similarity | NPC311680 |
0.9593 | High Similarity | NPC126836 |
0.9593 | High Similarity | NPC51840 |
0.959 | High Similarity | NPC154866 |
0.959 | High Similarity | NPC28765 |
0.9576 | High Similarity | NPC166759 |
0.9512 | High Similarity | NPC212015 |
0.9508 | High Similarity | NPC252131 |
0.9508 | High Similarity | NPC266555 |
0.9508 | High Similarity | NPC210355 |
0.9508 | High Similarity | NPC236760 |
0.9508 | High Similarity | NPC127587 |
0.95 | High Similarity | NPC282496 |
0.95 | High Similarity | NPC197757 |
0.95 | High Similarity | NPC136319 |
0.95 | High Similarity | NPC121115 |
0.95 | High Similarity | NPC228922 |
0.95 | High Similarity | NPC233526 |
0.9492 | High Similarity | NPC247364 |
0.9492 | High Similarity | NPC474565 |
0.9492 | High Similarity | NPC232084 |
0.9492 | High Similarity | NPC61516 |
0.9492 | High Similarity | NPC10932 |
0.944 | High Similarity | NPC6451 |
0.9435 | High Similarity | NPC214860 |
0.9431 | High Similarity | NPC98631 |
0.9431 | High Similarity | NPC206615 |
0.9431 | High Similarity | NPC186843 |
0.9431 | High Similarity | NPC266691 |
0.9431 | High Similarity | NPC470213 |
0.9426 | High Similarity | NPC223953 |
0.9426 | High Similarity | NPC76451 |
0.9421 | High Similarity | NPC183446 |
0.9417 | High Similarity | NPC41562 |
0.9407 | High Similarity | NPC226629 |
0.9365 | High Similarity | NPC471391 |
0.9365 | High Similarity | NPC475840 |
0.9365 | High Similarity | NPC471390 |
0.9365 | High Similarity | NPC229442 |
0.9365 | High Similarity | NPC168059 |
0.9365 | High Similarity | NPC32778 |
0.9365 | High Similarity | NPC36661 |
0.936 | High Similarity | NPC12275 |
0.936 | High Similarity | NPC232275 |
0.936 | High Similarity | NPC474356 |
0.936 | High Similarity | NPC45715 |
0.9355 | High Similarity | NPC476968 |
0.9355 | High Similarity | NPC45824 |
0.9355 | High Similarity | NPC170844 |
0.9291 | High Similarity | NPC317380 |
0.9286 | High Similarity | NPC86655 |
0.9286 | High Similarity | NPC202762 |
0.9286 | High Similarity | NPC127624 |
0.928 | High Similarity | NPC91291 |
0.928 | High Similarity | NPC192687 |
0.928 | High Similarity | NPC224157 |
0.928 | High Similarity | NPC472338 |
0.9262 | High Similarity | NPC228972 |
0.9262 | High Similarity | NPC122792 |
0.9262 | High Similarity | NPC5796 |
0.9262 | High Similarity | NPC206487 |
0.9244 | High Similarity | NPC20674 |
0.9237 | High Similarity | NPC259638 |
0.9219 | High Similarity | NPC108198 |
0.9219 | High Similarity | NPC474206 |
0.9219 | High Similarity | NPC158142 |
0.9219 | High Similarity | NPC472337 |
0.9219 | High Similarity | NPC94750 |
0.9219 | High Similarity | NPC69029 |
0.9219 | High Similarity | NPC200557 |
0.9219 | High Similarity | NPC121812 |
0.9219 | High Similarity | NPC313081 |
0.9219 | High Similarity | NPC112246 |
0.9219 | High Similarity | NPC10314 |
0.9219 | High Similarity | NPC256262 |
0.9219 | High Similarity | NPC294884 |
0.9219 | High Similarity | NPC112939 |
0.9219 | High Similarity | NPC470356 |
0.9206 | High Similarity | NPC472597 |
0.9206 | High Similarity | NPC474017 |
0.9206 | High Similarity | NPC470096 |
0.9206 | High Similarity | NPC15543 |
0.9206 | High Similarity | NPC470095 |
0.92 | High Similarity | NPC470633 |
0.92 | High Similarity | NPC469963 |
0.92 | High Similarity | NPC228769 |
0.92 | High Similarity | NPC190144 |
0.92 | High Similarity | NPC469951 |
0.9194 | High Similarity | NPC216836 |
0.9194 | High Similarity | NPC242032 |
0.9194 | High Similarity | NPC470699 |
0.918 | High Similarity | NPC84086 |
0.9174 | High Similarity | NPC145780 |
0.9174 | High Similarity | NPC49341 |
0.9167 | High Similarity | NPC229401 |
0.9153 | High Similarity | NPC203113 |
0.9153 | High Similarity | NPC123948 |
0.9153 | High Similarity | NPC193067 |
0.9147 | High Similarity | NPC143139 |
0.9147 | High Similarity | NPC202846 |
0.9147 | High Similarity | NPC16435 |
0.9147 | High Similarity | NPC248727 |
0.9147 | High Similarity | NPC265433 |
0.9147 | High Similarity | NPC270456 |
0.9147 | High Similarity | NPC227503 |
0.9147 | High Similarity | NPC230734 |
0.9147 | High Similarity | NPC474639 |
0.9147 | High Similarity | NPC306441 |
0.9147 | High Similarity | NPC472334 |
0.9147 | High Similarity | NPC162659 |
0.9147 | High Similarity | NPC472336 |
0.9141 | High Similarity | NPC289258 |
0.9141 | High Similarity | NPC276026 |
0.9141 | High Similarity | NPC206737 |
0.9141 | High Similarity | NPC56764 |
0.9141 | High Similarity | NPC209199 |
0.9141 | High Similarity | NPC125649 |
0.9141 | High Similarity | NPC469659 |
0.9141 | High Similarity | NPC555 |
0.9141 | High Similarity | NPC7515 |
0.9141 | High Similarity | NPC188378 |
0.9134 | High Similarity | NPC160991 |
0.9134 | High Similarity | NPC16208 |
0.9134 | High Similarity | NPC184447 |
0.9134 | High Similarity | NPC7903 |
0.9134 | High Similarity | NPC201587 |
0.9134 | High Similarity | NPC35932 |
0.9134 | High Similarity | NPC253105 |
0.9127 | High Similarity | NPC474481 |
0.9113 | High Similarity | NPC181361 |
0.9113 | High Similarity | NPC112596 |
0.9083 | High Similarity | NPC475961 |
0.9083 | High Similarity | NPC254625 |
0.9077 | High Similarity | NPC6262 |
0.9077 | High Similarity | NPC107551 |
0.9077 | High Similarity | NPC276490 |
0.9077 | High Similarity | NPC211549 |
0.9077 | High Similarity | NPC474282 |
0.9077 | High Similarity | NPC326797 |
0.9077 | High Similarity | NPC102904 |
0.9077 | High Similarity | NPC90615 |
0.9077 | High Similarity | NPC176051 |
0.9077 | High Similarity | NPC73535 |
0.9077 | High Similarity | NPC103976 |
0.9077 | High Similarity | NPC272157 |
0.9077 | High Similarity | NPC56329 |
0.9077 | High Similarity | NPC242715 |
0.9077 | High Similarity | NPC201145 |
0.9077 | High Similarity | NPC25111 |
0.907 | High Similarity | NPC180602 |
0.907 | High Similarity | NPC241241 |
0.907 | High Similarity | NPC214853 |
0.907 | High Similarity | NPC234333 |
0.907 | High Similarity | NPC61946 |
0.907 | High Similarity | NPC55239 |
0.907 | High Similarity | NPC47398 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC82483 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9355 | High Similarity | NPD3027 | Phase 3 |
0.8968 | High Similarity | NPD1529 | Clinical (unspecified phase) |
0.8889 | High Similarity | NPD1530 | Clinical (unspecified phase) |
0.8889 | High Similarity | NPD3018 | Phase 2 |
0.8837 | High Similarity | NPD1613 | Approved |
0.8837 | High Similarity | NPD1612 | Clinical (unspecified phase) |
0.872 | High Similarity | NPD2983 | Phase 2 |
0.872 | High Similarity | NPD2982 | Phase 2 |
0.864 | High Similarity | NPD2981 | Phase 2 |
0.8571 | High Similarity | NPD228 | Approved |
0.8425 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.8279 | Intermediate Similarity | NPD5283 | Phase 1 |
0.8244 | Intermediate Similarity | NPD4908 | Phase 1 |
0.824 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8175 | Intermediate Similarity | NPD3540 | Phase 1 |
0.8125 | Intermediate Similarity | NPD1610 | Phase 2 |
0.812 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8102 | Intermediate Similarity | NPD3539 | Phase 1 |
0.8082 | Intermediate Similarity | NPD2801 | Approved |
0.8014 | Intermediate Similarity | NPD1934 | Approved |
0.7973 | Intermediate Similarity | NPD3882 | Suspended |
0.7951 | Intermediate Similarity | NPD3021 | Approved |
0.7951 | Intermediate Similarity | NPD3022 | Approved |
0.791 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7881 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7874 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7868 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7863 | Intermediate Similarity | NPD4749 | Approved |
0.7862 | Intermediate Similarity | NPD1653 | Approved |
0.7838 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7832 | Intermediate Similarity | NPD4357 | Discontinued |
0.7832 | Intermediate Similarity | NPD1511 | Approved |
0.7727 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7724 | Intermediate Similarity | NPD1512 | Approved |
0.7721 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.771 | Intermediate Similarity | NPD422 | Phase 1 |
0.7687 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7667 | Intermediate Similarity | NPD846 | Approved |
0.7667 | Intermediate Similarity | NPD940 | Approved |
0.7635 | Intermediate Similarity | NPD4678 | Approved |
0.7635 | Intermediate Similarity | NPD4675 | Approved |
0.7632 | Intermediate Similarity | NPD6234 | Discontinued |
0.763 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7616 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7615 | Intermediate Similarity | NPD1357 | Approved |
0.7613 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7613 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7613 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7609 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7609 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7591 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD3705 | Approved |
0.7576 | Intermediate Similarity | NPD1091 | Approved |
0.7569 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7569 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7552 | Intermediate Similarity | NPD3060 | Approved |
0.755 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7537 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7536 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7533 | Intermediate Similarity | NPD37 | Approved |
0.752 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7517 | Intermediate Similarity | NPD7124 | Phase 2 |
0.75 | Intermediate Similarity | NPD290 | Approved |
0.7484 | Intermediate Similarity | NPD6232 | Discontinued |
0.7482 | Intermediate Similarity | NPD1240 | Approved |
0.7468 | Intermediate Similarity | NPD7054 | Approved |
0.7464 | Intermediate Similarity | NPD3144 | Approved |
0.7464 | Intermediate Similarity | NPD3145 | Approved |
0.7458 | Intermediate Similarity | NPD9296 | Approved |
0.7451 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.745 | Intermediate Similarity | NPD4005 | Discontinued |
0.7442 | Intermediate Similarity | NPD6671 | Approved |
0.744 | Intermediate Similarity | NPD2684 | Approved |
0.7429 | Intermediate Similarity | NPD230 | Phase 1 |
0.7421 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7421 | Intermediate Similarity | NPD7472 | Approved |
0.7419 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7413 | Intermediate Similarity | NPD7266 | Discontinued |
0.7405 | Intermediate Similarity | NPD3818 | Discontinued |
0.7394 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7386 | Intermediate Similarity | NPD4966 | Approved |
0.7386 | Intermediate Similarity | NPD4965 | Approved |
0.7386 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7376 | Intermediate Similarity | NPD1607 | Approved |
0.7372 | Intermediate Similarity | NPD9494 | Approved |
0.7365 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7357 | Intermediate Similarity | NPD943 | Approved |
0.7347 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7344 | Intermediate Similarity | NPD7843 | Approved |
0.7342 | Intermediate Similarity | NPD7473 | Discontinued |
0.7338 | Intermediate Similarity | NPD4055 | Discovery |
0.7325 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD6111 | Discontinued |
0.7315 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7311 | Intermediate Similarity | NPD2934 | Approved |
0.7311 | Intermediate Similarity | NPD2933 | Approved |
0.731 | Intermediate Similarity | NPD4236 | Phase 3 |
0.731 | Intermediate Similarity | NPD5177 | Phase 3 |
0.731 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD4237 | Approved |
0.7308 | Intermediate Similarity | NPD7157 | Approved |
0.7297 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD4123 | Phase 3 |
0.7297 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7296 | Intermediate Similarity | NPD7228 | Approved |
0.7292 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7285 | Intermediate Similarity | NPD4380 | Phase 2 |
0.728 | Intermediate Similarity | NPD968 | Approved |
0.7279 | Intermediate Similarity | NPD8651 | Approved |
0.7267 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7255 | Intermediate Similarity | NPD1465 | Phase 2 |
0.725 | Intermediate Similarity | NPD2859 | Approved |
0.725 | Intermediate Similarity | NPD2860 | Approved |
0.7241 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD7213 | Phase 3 |
0.723 | Intermediate Similarity | NPD7212 | Phase 2 |
0.723 | Intermediate Similarity | NPD6799 | Approved |
0.7222 | Intermediate Similarity | NPD2935 | Discontinued |
0.7222 | Intermediate Similarity | NPD6100 | Approved |
0.7222 | Intermediate Similarity | NPD7251 | Discontinued |
0.7222 | Intermediate Similarity | NPD6099 | Approved |
0.7214 | Intermediate Similarity | NPD5109 | Approved |
0.7214 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7214 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7213 | Intermediate Similarity | NPD3020 | Approved |
0.7211 | Intermediate Similarity | NPD6190 | Approved |
0.7195 | Intermediate Similarity | NPD8053 | Approved |
0.7195 | Intermediate Similarity | NPD8054 | Approved |
0.7194 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7192 | Intermediate Similarity | NPD6674 | Discontinued |
0.7181 | Intermediate Similarity | NPD1424 | Approved |
0.7178 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7178 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7174 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7172 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7172 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7164 | Intermediate Similarity | NPD4626 | Approved |
0.7143 | Intermediate Similarity | NPD2978 | Approved |
0.7143 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7143 | Intermediate Similarity | NPD2977 | Approved |
0.7143 | Intermediate Similarity | NPD7095 | Approved |
0.7143 | Intermediate Similarity | NPD3750 | Approved |
0.7143 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7124 | Intermediate Similarity | NPD5090 | Approved |
0.7124 | Intermediate Similarity | NPD5089 | Approved |
0.7123 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7115 | Intermediate Similarity | NPD7075 | Discontinued |
0.7114 | Intermediate Similarity | NPD5297 | Approved |
0.7113 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7109 | Intermediate Similarity | NPD5451 | Approved |
0.7105 | Intermediate Similarity | NPD6055 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7097 | Intermediate Similarity | NPD291 | Approved |
0.7097 | Intermediate Similarity | NPD6374 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD2677 | Approved |
0.7092 | Intermediate Similarity | NPD6798 | Discontinued |
0.7092 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7083 | Intermediate Similarity | NPD4536 | Approved |
0.7083 | Intermediate Similarity | NPD4538 | Approved |
0.7083 | Intermediate Similarity | NPD4537 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD4162 | Approved |
0.7063 | Intermediate Similarity | NPD6355 | Discontinued |
0.7063 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7063 | Intermediate Similarity | NPD447 | Suspended |
0.7063 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7054 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD6788 | Approved |
0.7045 | Intermediate Similarity | NPD709 | Approved |
0.7037 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7037 | Intermediate Similarity | NPD5846 | Approved |
0.7037 | Intermediate Similarity | NPD1778 | Approved |
0.7034 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.7034 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD3225 | Approved |
0.7027 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD5494 | Approved |
0.702 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7014 | Intermediate Similarity | NPD4097 | Suspended |
0.7007 | Intermediate Similarity | NPD2233 | Approved |
0.7007 | Intermediate Similarity | NPD2230 | Approved |
0.7007 | Intermediate Similarity | NPD2232 | Approved |
0.7006 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD7261 | Clinical (unspecified phase) |
0.6986 | Remote Similarity | NPD2796 | Approved |
0.6985 | Remote Similarity | NPD3496 | Discontinued |
0.6985 | Remote Similarity | NPD3847 | Discontinued |
0.698 | Remote Similarity | NPD5241 | Discontinued |
0.697 | Remote Similarity | NPD7549 | Discontinued |
0.6967 | Remote Similarity | NPD844 | Approved |
0.6966 | Remote Similarity | NPD6896 | Approved |
0.6966 | Remote Similarity | NPD6895 | Approved |
0.6957 | Remote Similarity | NPD6583 | Phase 3 |
0.6957 | Remote Similarity | NPD6582 | Phase 2 |
0.6954 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6953 | Remote Similarity | NPD1358 | Approved |
0.6949 | Remote Similarity | NPD9094 | Approved |
PubChem CID   | 5458993 |
ChEMBL   | CHEMBL36255 |
ZINC   |
Molecular Weight:   | 332.13 |
ALogP:   | -0.66 |
MLogP:   | 2.78 |
XLogP:   | 2.63 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 77.38 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 24 |